Merck/Schering Unbranded Ad Spotlights “Two Sources” Of High Cholesterol
This article was originally published in The Pink Sheet Daily
Executive Summary
The TV commercial launched three days after FDA approved the joint venture’s Zocor/Zetia combination Vytorin. The ad contains no suggestion of a branded product but highlights the hereditary and dietary causes of high cholesterol.
You may also be interested in...
Vioxx Withdrawal Has Not Affected Merck's Belief In DTC Advertising
Merck will continue to support its products with direct-to-consumer advertising campaigns despite the withdrawal of Vioxx, CEO Ray Gilmartin said Jan. 11 at the J.P. Morgan health care conference in San Francisco
Vioxx Withdrawal Has Not Affected Merck's Belief In DTC Advertising
Merck will continue to support its products with direct-to-consumer advertising campaigns despite the withdrawal of Vioxx, CEO Ray Gilmartin said Jan. 11 at the J.P. Morgan health care conference in San Francisco
Merck/Schering's Vytorin Priced At 22% Discount To Pfizer's Lipitor
The ezetimibe/simvastatin combination is priced at a 39% discount to the three highest doses of Merck's Zocor. Vytorin will launch in August at a wholesale acquisition cost of $2.34 per day.